Predictive Oncology Inc. (NASDAQ:POAI – Get Free Report)’s share price crossed below its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $6.65 and traded as low as $5.85. Predictive Oncology shares last traded at $6.05, with a volume of 527,226 shares changing hands.
Predictive Oncology Trading Up 11.2%
The company has a market cap of $22.84 million, a P/E ratio of -0.50 and a beta of 1.35. The company’s fifty day moving average is $10.18 and its 200 day moving average is $6.65.
Predictive Oncology Company Profile
Predictive Oncology Inc (NASDAQ: POAI) is a biotechnology company focused on applying artificial intelligence, machine learning, and laboratory-based cancer research to drug discovery and precision oncology. The company uses tumor samples and related biological data to study how individual cancers may respond to potential treatments.
Its technology offerings have included AI-enabled platforms designed to analyze cancer data, identify potential drug candidates, and predict treatment responses.
Featured Articles
- Five stocks we like better than Predictive Oncology
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for Predictive Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Predictive Oncology and related companies with MarketBeat.com's FREE daily email newsletter.
